vimarsana.com

Latest Breaking News On - Marc andrea baertsch - Page 1 : vimarsana.com

No Benefit to Salvage Transplant in R/R Multiple Myeloma

Long-term follow-up shows no progression-free or overall survival advantage among patients who received salvage transplant vs continuous lenalidomide plus dexamethasone.

Salt-lake-city
Utah
United-states
Heidelberg
Baden-wüberg
Germany
University-of-utah
German
American
Manni-mohyuddin
Marc-andrea-baertsch
University-hospital-heidelberg

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.